ORI
SAGE

Oak Ridge Investments’s Sage Therapeutics SAGE Stock Holding History

Oak Ridge Investments’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-53,539
Closed -$3.87M – 186
2019
Q4 		$3.87M Sell
53,539
-46,329
-46% -$5.7M 0.28% 105
2019
Q3 		$14M Sell
99,868
-6,077
-6% -$1.02M 1.05% 35
2019
Q2 		$19.4M Sell
105,945
-14,750
-12% -$2.52M 1.34% 15
2019
Q1 		$19.2M Sell
120,695
-110,788
-48% -$16M 1.22% 20
2018
Q4 		$22.2M Sell
231,483
-9,616
-4% -$1.1M 1.6% 13
2018
Q3 		$34.1M Sell
241,099
-18,729
-7% -$2.89M 1.88% 8
2018
Q2 		$40.7M Sell
259,828
-19,831
-7% -$3.11M 2.3% 6
2018
Q1 		$45M Sell
279,659
-66,938
-19% -$11.4M 2.5% 3
2017
Q4 		$57.1M Sell
346,597
-390,112
-53% -$37.8M 2.72% 1
2017
Q3 		$45.9M Buy
736,709
+6,835
+0.9% +$537K 1.86% 6
2017
Q2 		$58.1M Sell
729,874
-91,196
-11% -$6.59M 1.85% 11
2017
Q1 		$58.4M Sell
821,070
-193,457
-19% -$11.3M 1.96% 10
2016
Q4 		$51.8M Sell
1,014,527
-139,954
-12% -$6.6M 1.68% 22
2016
Q3 		$53.2M Buy
1,154,481
+515,180
+81% +$21M 1.38% 27
2016
Q2 		$19.3M Sell
639,301
-13,852
-2% -$462K 0.49% 63
2016
Q1 		$20.9M Buy
653,153
+1,733
+0.3% +$61K 0.53% 62
2015
Q4 		$38M Sell
651,420
-8,798
-1% -$436K 0.91% 43
2015
Q3 		$27.9M Sell
660,218
-677
-0.1% -$41.7K 0.67% 50
2015
Q2 		$48.2M Buy
660,895
+275,125
+71% +$17.7M 1.02% 39
2015
Q1 		$19.4M Buy
+385,770
New +$16.6M 0.43% 69

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Oak Ridge Investments's SAGE Position: Q1 2020 in Review

Oak Ridge Investments sold out of Sage Therapeutics (SAGE) in Q1 2020, closing a stake of 53,539 shares — an estimated $3.87M sold.

Oak Ridge Investments first reported a position in SAGE in Q1 2015 and held it in 20 quarters. The position peaked at $58.4M in Q1 2017. 230 funds tracked by Wall St. Rank hold SAGE as of Q1 2020.

  • Oak Ridge Investments reported no remaining Sage Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Oak Ridge Investments sold 53,539 Sage Therapeutics shares in Q1 2020, an estimated $3.87M.
  • Oak Ridge Investments first reported a position in Sage Therapeutics in Q1 2015 and held it in 20 quarters.
  • Oak Ridge Investments's Sage Therapeutics position peaked at $58.4M in Q1 2017.
  • 230 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2020.

Based on Oak Ridge Investments's 13F filing for Q1 2020, filed 13 May 2020.